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Ring test evaluation of the detection of influenza A virus in swine oral
fluids by real-time reverse-transcription polymerase chain reaction and
virus isolation
Abstract
The probability of detecting influenza A virus (IAV) in oral fluid (OF) specimens was calculated for each of 13
assays based on real-time reverse-transcription polymerase chain reaction (rRT-PCR) and 7 assays based on
virus isolation (VI). The OF specimens were inoculated with H1N1 or H3N2 IAV and serially diluted 10-fold
(10(-1) to 10(-8)). Eight participating laboratories received 180 randomized OF samples (10 replicates × 8
dilutions × 2 IAV subtypes plus 20 IAV-negative samples) and performed the rRT-PCR and VI procedure(s)
of their choice. Analysis of the results with a mixed-effect logistic-regression model identified dilution and
assay as variables significant (P < 0.0001) for IAV detection in OF by rRT-PCR or VI. Virus subtype was not
significant for IAV detection by either rRT-PCR (P = 0.457) or VI (P = 0.101). For rRT-PCR the cycle
threshold (Ct) values increased consistently with dilution but varied widely. Therefore, it was not possible to
predict VI success on the basis of Ct values. The success of VI was inversely related to the dilution of the
sample; the assay was generally unsuccessful at lower virus concentrations. Successful swine health
monitoring and disease surveillance require assays with consistent performance, but significant differences in
reproducibility were observed among the assays evaluated.
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fluids by real-time reverse-transcription polymerase chain reaction  
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Marie Culhane, Jane Christopher-Hennings, Travis Clement, Pamela Leslie-Steen, Richard Hesse,  
Joe Anderson, Kevin Skarbek, Amy Vincent, Pravina Kitikoon, Sabrina Swenson,  
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A b s t r a c t
The probability of detecting influenza A virus (IAV) in oral fluid (OF) specimens was calculated for each of 13 assays based 
on real-time reverse-transcription polymerase chain reaction (rRT-PCR) and 7 assays based on virus isolation (VI). The OF 
specimens were inoculated with H1N1 or H3N2 IAV and serially diluted 10-fold (10−1 to 10−8). Eight participating laboratories 
received 180 randomized OF samples (10 replicates 3 8 dilutions 3 2 IAV subtypes plus 20 IAV-negative samples) and 
performed the rRT-PCR and VI procedure(s) of their choice. Analysis of the results with a mixed-effect logistic-regression model 
identified dilution and assay as variables significant (P , 0.0001) for IAV detection in OF by rRT-PCR or VI. Virus subtype was 
not significant for IAV detection by either rRT-PCR (P = 0.457) or VI (P = 0.101). For rRT-PCR the cycle threshold (Ct) values 
increased consistently with dilution but varied widely. Therefore, it was not possible to predict VI success on the basis of 
Ct values. The success of VI was inversely related to the dilution of the sample; the assay was generally unsuccessful at lower 
virus concentrations. Successful swine health monitoring and disease surveillance require assays with consistent performance, 
but significant differences in reproducibility were observed among the assays evaluated.
Résumé
La probabilité de détecter le virus de l’influenza A (VIA) dans des échantillons de fluide oral (FO) a été calculée pour chacune des 13 épreuves 
basées sur une réaction d’amplification en chaine en temps réel utilisant la polymérase réverse (rRT-PCR) et 7 épreuves basées sur l’isolement 
viral (IV). Les échantillons de FO ont été inoculés avec du VIA H1N1 ou H3N2 et dilués en série par facteur de 10 (1021 à 1028). Huit 
laboratoires participants ont reçu 180 échantillons randomisés de FO (10 réplicats 3 8 dilutions 3 2 sous-types de VIA plus 20 échantillons 
témoins négatifs sans VIA) et ont réalisé la méthode de rRT-PCR et d’IV de leur choix. L’analyse des résultats à l’aide d’un modèle de 
régression logistique pour les effets mélangés a identifié la dilution et l’épreuve comme étant des variables significatives (P , 0,0001) pour 
la détection de VIA dans du FO par rRT-PCR ou IV. Le sous-type de virus n’était pas significatif pour la détection de VIA soit par rRT-PCR 
(P = 0,457) ou par IV (P = 0,101). Pour les épreuves rRT-PCR les valeurs seuils de cycle (Ct) augmentaient de manière constante avec la 
dilution mais variaient énormément. Ainsi, il n’était pas possible de prédire le succès de l’IV sur la base des valeurs de Ct. Le succès de l’IV 
était inversement relié à la dilution de l’échantillon; l’épreuve était généralement négative aux faibles concentrations de virus. Pour avoir 
du succès dans la surveillance des maladies et de la santé des porcs il est nécessaire d’avoir des épreuves avec des performances constantes, 
mais des différences significatives dans la reproductibilité ont été observées parmi les épreuves évaluées.
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I n t r o d u c t i o n
Influenza A virus (IAV) causes illness, death, and economic losses 
at all stages of pig production, particularly when infection occurs 
concurrently with infection by other respiratory pathogens such as 
Porcine reproductive and respiratory syndrome virus (PRRSV) (1). 
In addition, IAV is zoonotic and moves relatively easily between 
pigs and humans (1). There have been well-recognized pig-to-human 
transmission events, such as outbreaks at county fairs in Indiana (2) 
and Ohio (3), but human-to-pig transmission of IAV is now also well-
documented (4). In the United States influenzavirus infections in 
humans and swine are monitored by the Centers for Disease Control 
and Prevention (5) and the United States Department of Agriculture 
(USDA) (6). This effort tracks the regional distribution and genetic 
changes of viral subtypes circulating in human and swine popula-
tions. In pigs, current antemortem surveillance is based on indi-
vidual animal sampling (nasal swabs), although the short duration 
of shedding in nasal secretions greatly limits the probability of virus 
isolation (VI) or detection by real-time reverse-transcription poly-
merase chain reaction (rRT-PCR) after day 6 and day 8 of infection, 
respectively (7). This window of detection is reduced in vaccinated 
animals to day 4 and day 5 for VI and rRT-PCR, respectively (7). As 
an alternative to testing individual pig samples, assays of pen-based 
oral fluid (OF) specimens by rRT-PCR may be used to detect IAV for 
at least 14 d after inoculation in unvaccinated animals and at least 7 d 
in vaccinated animals (7). For ease of sampling and improved rates 
of IAV detection in swine populations, OF assays are gaining favor in 
surveillance programs (David Pyburn, USDA-APHIS, 2010 personal 
communication). Regardless of specimen, successful swine health 
monitoring and disease surveillance depend on reliable diagnostic 
assays. Various VI procedures, as well as commercial and in-house 
IAV rRT-PCR assays, are in place in veterinary diagnostic labora-
tories, but no direct comparisons of assay performance have been 
done on swine specimens. Although proficiency panels are useful in 
test validation and harmonization (8–10), they also serve to assess 
competence, supplement laboratory quality-control measures, and 
improve uniformity in assay performance (9,11–13). In follow-up 
performance studies in which identical protocols, reagents, and/or 
training were provided, greater assay reproducibility and repeat-
ability were observed (14–16). Ring tests are proficiency tests coor-
dinated among multiple collaborating laboratories (17). Inclusion of 
sufficient numbers of replicates and dilutions allows for statistical 
analysis of assay reproducibility (between laboratory) and repeat-
ability (within laboratory) and facilitates process improvement. The 
objectives of this study were to evaluate IAV OF assays, determine 
the correlation between rRT-PCR results and the probability of suc-
cessful VI, and identify the most sensitive rRT-PCR and VI protocols 
using a ring-test design.
M a t e r i a l s  a n d  m e t h o d s
Experimental design
The probability of detecting IAV in swine OF samples was calcu-
lated for each of 13 rRT-PCR and 7 VI assays done at 8 laboratories. 
Swine OF was inoculated with H1N1 or H3N2 IAV and diluted 
10-fold (10−1 to 10−8) serially. The complete sample set consisted 
of 180 randomized samples (10 replicates of each subtype at each 
dilution and 20 IAV-negative OF samples). A mixed-effect repeated-
measures logistic-regression model (Proc GLIMMIX, version 9.3; 
SAS Institute, Cary, North Carolina, USA) was used to determine 
the association between the detection of IAV and the variables of 
interest (IAV subtype, dilution, assay, and interactions).
Ring-test samples
The study was conducted with the use of 4 sows in isolation at the 
Iowa State University Livestock Infectious Disease Isolation Facility, 
Ames, Iowa. The protocol for the animal procedures was approved 
by the university’s Institutional Animal Care and Use Committee. 
The sows were clinically healthy, but to verify their health status 
before OF collection a serum sample was tested at the Iowa State 
University Veterinary Diagnostic Laboratory for evidence of infec-
tion with PRRS (IDEXX PRRS X3 Ab Test; IDEXX Laboratories, 
Westbrook, Maine, USA) (18), Mycoplasma hyopneumoniae (IDEXX M. 
hyo. Ab Test; IDEXX Laboratories) and IAV (IDEXX AI MultiS-Screen 
Ab Test; IDEXX Laboratories) with established laboratory proce-
dures (19). Oral fluid was collected by allowing the animals to chew 
on, and thus saturate, 5/8-inch 3-strand twisted 100% cotton rope 
(Web Rigging Supply, Lake Barrington, Illinois, USA) suspended in 
the pen. The wet portion of the rope was inserted into a resealable 
plastic bag and severed from the dry portion. The bag containing 
the wet rope was then passed through a wringer (Dyna-Jet Products, 
Overland Park, Kansas, USA), and the OF that pooled in the bottom 
of the bag was decanted into tubes. At the end of each daily collec-
tion the OF was centrifuged (at 13 000 3 g) for 10 min and stored in 
50-mL tubes at −80°C. The collection process was repeated for 28 d, 
until a total of 5.4 L was accumulated (20).
To prepare ring-test samples, OF was thawed, aggregated in a 
sterile 6-L flask, and mixed on a magnetic stir plate for 1 h in a 
biosafety cabinet. Negative-control samples were generated by 
dispensing 2.6-mL aliquots of aggregated OF into 3-mL cryovials. 
Sufficient aliquots were dispensed to supply 20 negative samples 
per sample set. Thereafter, the aggregated OF was split into 2 flasks 
for the creation of subtype-specific IAV stock solutions by adding 
either A/Swine/Ohio/511445/2007 g H1N1 virus (kindly provided 
by Dr. Amy Vincent, USDA National Animal Disease Center, Ames, 
Iowa) or A/Swine/Illinois/02907/2009 cluster IV H3N2 virus 
(kindly provided by Dr. Marie Culhane, University of Minnesota, 
St. Paul, Minnesota, USA) to 1 of the 2 flasks. Previously the viruses 
had been propagated on Madin–Darby canine kidney (MDCK) cells 
to a concentration of 1 3 106.5 median tissue culture infectious dose 
(TCID50) per milliliter. From these virus stock solutions, 10-fold dilu-
tions (10−1 to 10−8) of H1N1 and H3N2 were created and dispensed 
as 2.6-mL sample aliquots into 3-mL cryovials. Ten replicates per 
dilution of each viral subtype were created for each sample set. 
Thus, 1 sample set (180 samples) included 20 negative samples and 
160 IAV-inoculated samples (10 replicates of each IAV subtype at 
each dilution). Finally, 1 mL of each stock solution was retained for 
back titration.
Eight sample sets were prepared for distribution to participating 
laboratories. Each aliquot was identified by set number and a ran-
dom sample number between 1 and 180. The sample sets were sorted 
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by random number, stored at −80°C, and then shipped overnight on 
dry ice to the 8 laboratories. Temperature indicators (WarmMark 
Time-Temp Tags; ShockWatch, Graham, Texas, USA) were placed in 
each box (13 3 13 cm) of cryovials (60 samples) to detect exposure 
of the contents to temperatures of −18°C or higher during the ship-
ment process. The laboratories confirmed that the samples were still 
frozen and that the boxes contained dry ice at the time of arrival.
Samples were immediately returned to −80°C until tested at the 
recipient laboratory. All laboratories invited to participate had prior 
experience with molecular techniques for the detection of IAV in 
swine specimens including nasal swabs, tissue, and oral fluid. All 
invited laboratories agreed to participate. Each laboratory was at lib-
erty to perform the IAV rRT-PCR and VI procedure(s) of their choice. 
Among the 8 laboratories, 5 tested the samples using 1 rRT-PCR pro-
cedure, 2 laboratories conducted 2 PCR procedures, and 1 laboratory 
conducted 4 PCR procedures (PCR assays 1 to 13). Six laboratories 
conducted VI, one using 2 different methods (VI assays 1 to 7). 
Testing results were reported by sample number as binary (Yes/No) 
outcomes, along with cycle threshold (Ct) values for the rRT-PCR-
positive samples. Positive or negative rRT-PCR status was deter-
mined by each laboratory independently and according to previ-
ously established cut-off values for the particular assay, protocol, 
and equipment used.
Data analysis
The Proc GLIMMIX mixed-effect repeated-measures logistic-
regression model was used to analyze the binary responses: detection 
of IAV in OF by rRT-PCR (Yes/No) and VI (Yes/No). The explana-
tory variables of interest include dilution (10−1 through 10−8), virus 
subtype (H1N1 or H3N2), assay (PCR 1 to 13 or VI 1 to 7), and 
relevant interactions, with sample as a random effect. Fixed effects 
were considered significant at an a-value = 0.05. The degree of vari-
ability among all aspects of the assay protocols precluded statistical 
analysis of the individual components. Pairwise differences between 
assays were assessed with the use of Tukey’s t-tests. The probability 
of detecting IAV in known-positive OF samples by  dilution was 
Table I. Number of samples of swine oral fluid (OF) positive for influenza A virus (IAV) by real-time reverse-transcription polymerase 
chain reaction (rRT-PCR) and mean cycle threshold (Ct) value by dilutiona (assays listed in descending order of performance)
 Dilution, number of samples, and mean Ct value
 Swine OF with H1N1c Swine OF with H3N2d
Assay Lab Neg.b 10−1 10−2 10−3 10−4 10−5 10−6 10−7 10−8 10−1 10−2 10−3 10−4 10−5 10−6 10−7 10−8
PCR 1 G  1 10 10 10 10 10 10  5  1 10 10 10 10 10  6  1  0
  36.3 16.6 19.9 23.2 26.5 29.9 33.3 35.4 36.1 19.7 22.9 26.1 29.5 32.6 35.7 36.2 —
PCR 2 A  1 10 10 10 10 10 10  2  1 10 10 10 10 10  5  2  1
  39.2 19.9 23.5 27.0 30.4 33.8 37.3 39.6 39.5 19.7 22.9 26.1 29.4 37.3 39.0 39.0 39.8
PCR 3 G  2 10 10 10 10 10 10  4  1 10 10 10 10 10  3  1  0
  37.7 18.7 22.1 25.4 28.6 32.0 35.6 36.9 38.5 21.7 25.2 28.4 31.6 34.7 36.0 36.7 —
PCR 4 G  0 10 10 10 10 10 10  7  0 10 10 10 10 10  6  0  0
  — 18.6 21.8 25.1 28.6 32.2 35.4 37.3 — 21.6 24.6 28.3 31.7 35.0 37.6 — —
PCR 5 D  1 10 10 10 10 10 10  1  1 10 10 10 10 10  0  1  0
  34.2 18.1 21.6 25.0 28.2 31.0 35.4 36.0 35.4 21.3 25.0 28.1 31.2 33.1 — 33.3 —
PCR 6 H  2 10 10 10 10 10  3  0  0 10 10 10 10 10 —  3  1
  37.5 21.6 25.1 28.8 31.8 35.6 41.5 — — 21.0 24.5 27.8 31.3 35.3 37.0 36.2 36.9
PCR 7 D  1 10 10 10 10 10  5  0  1 10 10 10 10 10  0  1  0
  36.9 20.5 23.9 27.7 31.0 34.8 37.7 — 37.5 22.1 26.0 29.5 33.0 35.8 — 37.3 —
PCR 8 E  1 10 10 10 10  8  1  1  2 10 10 10  9  6  5  2  0
  39.1 23.1 26.7 29.7 34.4 38.2 35.6 36.4 35.4 23.4 27.7 29.9 34.6 36.7 35.7 38.4 —
PCR 9 G  1 10 10 10 10 10  6  0  1 10 10 10 10  9  1  0  1
  36.0 20.8 24.8 28.2 31.2 35.0 37.7 — 38.8 23.8 27.3 30.6 33.8 36.4 38.8 — 37.2
PCR 10 F  2 10 10 10 10  3  1  0  0 10 10 10 10  9  0  2  1
  40.2 24.7 28.2 31.1 34.1 41.1 37.8 — — 23.5 27.1 30.4 34.0 37.4 — 40.5 39.9
PCR 11 C  1 10 10 10  9  5  1  0  0 10 10 10 10  9  4  0  0
  39.0 26.3 29.5 32.8 36.4 39.2 42.3 — — 24.1 27.7 31.2 34.7 38.0 38.6 — —
PCR 12 B  1 10 10 10 10 10  1  1  0 10 10  9  6  0  0  0  0
  33.7 22.3 26.2 29.5 32.6 36.1 38.6 38.1 — 25.8 29.3 32.9 35.9 — — — —
PCR 13 E  0 10 10 10  8  2  0  0  2 10  9 10  9  5  1  1  0
  — 22.8 26.8 29.2 34.0 36.9 — — 33.6 22.2 25.4 28.5 32.2 34.7 33.6 38.5 —
a  Results based on a sample set composed of 20 negative controls and 10 samples at each dilution (10−1 to 10−8) for each IAV subtype.
b Detection represents false-positive results.
c For undiluted fluid the concentration [median tissue culture infective dose per milliliter (TCID50/mL)] of the g H1N1 virus A/Swine/Ohio/ 
511445/2007 was estimated at 1 3 107.5/mL.
d For undiluted fluid the concentration of the cluster IV H3N2 virus A/Swine/Illinois/02907/2009 was estimated at 1 3 106.6/mL.
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estimated for rRT-PCR and VI tests from the mixed-effect repeated-
measures logistic-regression model. This model was also used to 
estimate the detection dose 50 (DD50) for each assay; that is, the 
inoculum dilution at which there was a 50% probability of detection.
Re s u l t s
All sow serum was negative for evidence of exposure to PRRSV, 
M. hyopneumoniae, and IAV. Back titration of the virus stock solu-
tions estimated the initial concentrations at 1 3 107.5 TCID50/mL and 
1 3 106.57 TCID50/mL for the H1N1 and H3N2 viruses, respectively.
Table I shows the rRT-PCR test results by assay. Of the 13 assays 
11 reported at least 1 false-positive result among the 20 negative 
samples. All the assays detected virus in all the H1N1-inoculated 
samples through the 10−3 dilution, after which detection decreased 
by assay and dilution. For the H3N2-inoculated samples all the 
assays detected virus in 10 of 10 samples at the 10−1 dilution, and 
12 of the 13 assays detected virus in 10 of 10 samples at the 10−2 and 
10−3 dilutions, after which detection decreased by assay and dilution. 
The mean Ct values by dilution varied widely among the assays, 
although the values increased consistently within each assay as the 
dilution increased (Figure 1).
Table II shows the VI results by assay. Successful isolation was 
inversely related to sample dilution. One assay reported a sin-
gle false-positive result among the 20 negative samples. Virus 
was detected in all H1N1- and H3N2-inoculated samples at the 
10−1 dilution in 6 of the 7 assays; the probability of VI decreased by 
assay and dilution thereafter.
Analysis of the data in the mixed-effect logistic-regression model 
identified the variables significant to IAV detection in OF by rRT-
PCR or VI as dilution (P , 0.0001) and assay (P , 0.0001). Virus 
subtype was not significant to IAV detection by rRT-PCR (P = 0.457) 
or VI (P = 0.101). The interaction between dilution and subtype was 
also not significant for detection by either rRT-PCR or VI (P = 0.757 
and P = 0.066, respectively). Therefore, virus subtype was subsumed 
into a single variable for subsequent analyses.
The probability (Pr) of IAV detection over dilution was calculated 
with the following equations.
Equation 1: l = Logit(P(X)) = a 1 b1X1 1 b2X2
Where:
a = intercept
b1 = regression coefficient for concentration
b2 =  regression coefficients for assay procedure
Equation 2: Probability (Pr) = e(l)/(1 1 e(l))
The probability of detecting IAV by rRT-PCR as a function of 
dilution is shown in Figure 2. Notably, there was a 102 range 
in DD50 between the lowest-performing and highest-performing 
assays: 1 3 10−4.68 versus 1 3 10−6.68. Pairwise comparisons among 
the 13 assays identified significantly different levels of detection 
performance; assays 1, 2, and 3 exhibited the highest performance 
and were statistically equivalent. The protocols for these 3 assays 
are given in the Appendix.
Figure 1. Distribution of cycle threshold (Ct) values from real-time reverse-transcription polymerase chain reaction (rRT-PCR) assay of influenza A virus 
(IAV) in serially diluted swine oral fluid (OF) obtained from all virus-positive results from each laboratory, by virus subtype (H1N1 or H3N2) and dilution.
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The probability of isolating IAV from OF as a function of dilution 
is shown in Figure 3. Significantly different levels of performance 
were identified among the VI assays, with a 102.67 range in DD50 
between the lowest-performing and highest-performing assays: 
1 3 10−1.41 versus 1 3 10−4.08. Virus isolation was generally unsuc-
cessful at dilutions greater than 10−4. Pairwise comparisons among 
the 7 assays identified significantly different levels of performance; 
assays 1 and 2 showed the highest performance and were statisti-
cally equivalent. The protocols for these 2 assays are given in the 
Appendix.
An evaluation of the relationship between the rRT-PCR Ct values 
and VI positivity determined that the probability of a positive rRT-PCR 
result had no association with the probability of successful VI within 
the same laboratory except for the dilutions with the highest concen-
trations of virus. This absence of an association resulted from the vari-
ability in both PCR Ct values and VI performance within laboratories.
Table II. Number of samples from which IAV was isolated, by dilution (assays listed in descending order of performance)
 Dilution and number of samples
 Swine OF with H1N1 Swine OF with H3N2
Assay Laba Neg. 10−1 10−2 10−3 10−4 10−5 10−6 10−7 10−8 10−1 10−2 10−3 10−4 10−5 10−6 10−7 10−8
VI 1 E 0 10 10 10 8 3 1 1 0 10 10 10 5 1 2 0 0
VI 2 F 0 10 10  9 9 2 1 0 0 10  9 10 9 1 0 0 0
VI 3 B 0 10 10 10 6 1 0 0 0 10 10  9 4 0 0 0 0
VI 4 H 0 10 10  9 2 0 0 0 0 10 10 10 2 0 0 0 0
VI 5 C 1 10  9  1 0 0 0 0 0 10 10  3 2 0 0 0 0
VI 6 D 0 10  4  1 0 0 0 0 0 10  7  1 1 0 0 0 0
VI 7 C 0  9  4  1 0 0 0 0 0  8  6  1 0 0 0 0 0
a Not all of the 8 participating laboratories conducted virus isolation studies. All other footnotes as for Table I.
Figure 2. Probability of detecting IAV in swine OF by rRT-PCR according to combined H1N1 and H3N2 test results. Differences between superscripts 
reflect significant differences (P , 0.05) in assay performance between the 13 assays. Duplicate line patterns of the same color indicate identical 
probability curves. DD50 — detection dose 50; that is, the inoculum dilution at which there was a 50% probability of detection.
Influenza A virus in swine oral fluid (10-fold dilutions)
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D i s c u s s i o n
The use of OF specimens for the detection of IAV infections in 
swine is a relatively recent innovation (7,21,22) but is compatible 
with previous reports on the use of such specimens in human and 
veterinary diagnostics (23). In particular, pen-based OF specimens 
provide the advantage of a higher probability of disease detection 
in populations compared with samples collected from individual 
animals (7,22,24,25). For example, Romagosa et al (22) reported that 
the probability of detecting IAV in swine OF by rRT-PCR was 69% 
when the prevalence of infection in a pen was 9% and 99% when the 
prevalence was 10% or greater.
The primary aim of this study was to evaluate the performance 
of rRT-PCR and VI assays for the detection of IAV in swine OF 
specimens. Interlaboratory assessment of molecular diagnostic assay 
performance is challenging because procedures are often nonuniform 
among veterinary diagnostic laboratories and because the technol-
ogy continues to evolve at a rapid pace. In this study, performance 
was assessed by analyzing and ranking 13 rRT-PCR and 7 VI assays 
using results from identical sets of samples tested at 8 laboratories. 
The analysis identified marked differences in rRT-PCR and VI perfor-
mance and a general lack of reproducibility among the participating 
laboratories. These results were compatible with the results of previ-
ous ring-test studies, in which high variability was observed among 
diagnostic laboratories performing similar tests (26–30).
Although a recent publication compared MDCK cells with embry-
onated eggs for isolation of IAV (31), no studies comparing IAV VI 
ring tests were found in the literature. Thus, there are no reports 
with which to compare the VI DD50 estimates (10
−1.41 to 10−4.08) in 
this study. However, comparison of these VI DD50 estimates with 
the DD50 estimates for the rRT-PCRs in this study (10
−4.68 to 10−6.68) 
confirms that PCR is a more analytically sensitive test. Although 
the mean Ct values (Figure 1) and the number of rRT-PCR-positive 
samples (Table I) correlated with the concentration of IAV in OF, 
the range of Ct values within dilutions demonstrated a substantial 
lack of precision. As a consequence, although samples with a higher 
virus concentration had a higher probability of virus detection by 
both rRT-PCR and VI, it was not possible to predict VI success on 
the basis of the Ct values.
A second aim of this study was to identify specific assay or labora-
tory factors associated with IAV detection in swine OF specimens. 
Achieving this aim is inherently difficult because of the number of 
potential sources of variability: the assay (the procedure, reagents, 
and equipment), the technician(s) performing the test, sample mis-
handling at any point in the chain of custody, and random errors 
introduced at any point in the process. Identifying factors affecting 
assay performance and reproducibility is further compromised by 
the fact that many sources of variability are difficult or impossible 
to document. In the case of molecular diagnostics, many of the com-
ponents that potentially affect performance are proprietary and not 
Figure 3. Probability of detecting IAV in swine OF by virus isolation according to combined H1N1 and H3N2 test results. 
Differences between superscripts reflect significant differences (P , 0.05) in assay performance between the 7 assays.
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available for analysis. Although the analysis in this study disclosed 
a large range in detection limits for both rRT-PCR and VI assays 
(a greater than 100-fold difference in the DD50 values), the vari-
ability in equipment, conditions, reagents, and protocols precluded 
statistical analysis that might have identified specific variables posi-
tively (or negatively) associated with detection. Furthermore, some 
laboratories participating in the study declined to provide complete 
protocols on the grounds of protecting intellectual property.
A possible weakness of the study was the uniformity of the OF 
specimens; that is, we used OF from 4 sows housed under experi-
mental conditions rather than field samples. However, this approach 
assured uniformity among samples and made it possible to gener-
ate the large number of samples (n = 1980) required for statistical 
analysis. In addition, there is no documented difference between 
experimental and field OF samples in terms of assay performance.
Assays based on PCR play an ever-larger role in routine diagnos-
tics because their diagnostic and analytic sensitivities are considered 
superior to those of VI, and they also provide for high throughput. 
However, issues with PCR reproducibility and repeatability were rec-
ognized soon after the method was introduced (32). To assure mini-
mum standards of PCR performance for high-consequence human 
pathogens, the European Union implemented proficiency testing 
of laboratories handling specimens from humans (32). Subsequent 
developments in PCR technology (e.g., single-tube reactions and 
robotic automation) have resulted in improvements that have been 
documented in proficiency testing over the last decade (9). Still, 
significant differences in assay performance remain, particularly in 
samples with lower target concentrations, as seen in this study and 
others (11,26,33,34). Both routine diagnostics and programmatic sur-
veillance require tests that provide accurate, consistent performance. 
Achieving this goal will require a collaborative approach that starts 
with more stringent requirements for validation of molecular assays 
and includes continuous, rigorous quality-control measures, such as 
proficiency panel and ring-trial assessments.
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Appendix. Optimal procedures for the diagnosis 
of influenza A virus (IAV) infection
Real-time reverse-transcription polymerase chain reaction  
(rRT-PCR) assay
Procedure 1 — Oral fluid (OF) specimens (200 mL) were centrifuged 
at 10 000 3 g for 30 s. Supernatant (140 mL) was extracted, purified, 
and processed with the QIAamp Viral Mini QIAcube kit (Qiagen, 
Valencia, California, USA) according to the manufacturer’s recom-
mendations. An inhibition control (Tetracore, Rockville, Maryland, 
USA) was incorporated into the extraction process and used as an 
extraction and PCR-inhibition control for each sample. The final elu-
tion volume of the extracted sample was 60 mL. Extracted samples 
were stored at 4°C and tested within a day.
The rRT-PCR assay was done with commercial reagents and a dry 
master mix (Universal Influenza A Matrix MPX 2.0; Tetracore) pre-
pared according to the manufacturer’s recommendations. For each 
reaction 20 mL of rehydrated master mix and 5 mL of sample were 
loaded into 1 well of a 96-well plate. The reactions were run with the 
following cycling conditions: 50°C for 30 min (stage 1), then 95°C for 
2 min (stage 2), followed by 45 cycles of 95°C for 15 s, 52°C for 15 s, 
and 60°C for 33 s (stage 3). The thermocycler (7500 Fast Real-Time 
PCR System; Applied Biosystems, Carlsbad, California, USA) was 
run in “standard” mode, and fluorescence data were collected dur-
ing the 60°C step in the FAM and CY5 channels. The baselines were 
set automatically and the thresholds set manually for each channel. 
A sample was considered positive for IAV if it yielded a FAM cycle 
threshold (Ct) value of less than 37. A sample was re-extracted and 
retested if it yielded a FAM Ct of 37 or more or a negative CY5 Ct, 
indicative of PCR inhibitors in the reaction.
Procedure 2 — Lysates were prepared by adding OF specimens 
(300 mL) to the lysis/binding solution in a commercial kit (MagMAX 
Pathogen RNA/DNA Kit; Applied Biosystems) and preclarified by 
centrifugation at 16 000 3 g for 2 min. Nucleic acid from the OF 
samples was extracted and purified from the entire lysate accord-
ing to the manufacturer’s recommendations with the same kit and 
the MagMAX Express-96 Magnetic Particle Processor (Applied 
Biosystems). The final elution volume of the extracted sample was 
90 mL. The extracted samples were stored at 4°C and tested within 
a day.
The rRT-PCR assay was done with commercial reagents (Swine 
Influenza Virus RNA Test Kit and VetMAX-Gold SIV Detection Kit; 
Applied Biosystems), and an internal control (Xeno RNA Control; 
Applied Biosystems) was used as an extraction and PCR-inhibition 
control for each sample. The rRT-PCR reaction was run with the 
following cycling conditions: 48°C for 10 min (stage 1), then 95°C 
for 10 min (stage 2), followed by 40 cycles of 95°C for 15 s and 
60°C for 45 s (stage 3). The thermocycler (7500 Fast Real-Time PCR 
System) was run in “standard” mode, and fluorescence data were 
collected during the 60°C annealing/extension stage. Analysis was 
done with the control-based threshold setting, with thresholds for 
swine influenzavirus RNA set at 5% of the positive control DRn at 
cycle 40. A sample was considered positive for IAV if it yielded a 
Ct value of less than 38.
Procedure 3 — Before extraction, OF specimens (280 mL) were cen-
trifuged at 10 000 3 g for 30 s. Supernatant (175 mL) was extracted 
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and purified with the MagMax 96 Viral RNA Isolation Kit (Applied 
Biosystems), with exceptions, according to the manufacturer ’s 
recommendations, and processed with the Qiagen BioSprint 96, 
according to the manufacturer’s recommendations, and the pro-
gram AM_1836_DW50_v2 of the KingFisher H 96 Magnetic Particle 
Processor (Thermo Fisher Scientific, Waltham, Massachusetts, USA). 
Exceptions to the extraction procedure were as follows: preparation 
of the lysis/binding solution [237 mL of lysis/binding solution con-
centrate (without isopropanol) and 3 mL of carrier RNA per reaction]; 
the lysis step [sample supernatant was added to the lysis/binding 
solution with 4 mL of inhibition control (QIAcube), then mixed and 
clarified by centrifugation at 14 000 3 g for 3 min]; and prepara-
tion of the lysis/binding plate (85 mL of bead mix, 65 mL of 100% 
isopropanol, and 115 mL of lysate added in order to each well). The 
remaining reagents were prepared according to the manufacturer’s 
recommendations. The final elution volume of the extracted sample 
was 75 mL. The extracted samples were stored at 4°C and tested 
within a day.
The rRT-PCR assay was done with commercial reagents and a 
dry master mix (Universal Influenza A Matrix MPX 2.0) prepared 
according to the manufacturer’s recommendations. For each reaction 
20 mL of rehydrated master mix and 5 mL of sample were loaded into 
1 well of a 96-well plate (MicroAmp Optical 96-Well Reaction Plate; 
Applied Biosystems). The reactions were run with the following 
cycling conditions: 50°C for 30 min (stage 1), then 95°C for 2 min 
(stage 2), followed by 45 cycles of 95°C for 15 s, 52°C for 15 s, and 
60°C for 33 s (stage 3). The thermocycler (7500 Fast Real-Time PCR 
System) was run in “standard” mode, and fluorescence data were 
collected during the 60°C step in the FAM and CY5 channels. The 
baselines were set automatically and the thresholds set manually for 
each channel. A sample was considered positive for IAV if it yielded 
a FAM Ct value of less than 37. A sample was re-extracted and 
retested if it yielded a FAM Ct of 37 or more or a negative CY5 Ct, 
indicative of PCR inhibitors in the reaction.
Virus isolation assay
Procedure 1 — The following protocol is fully described elsewhere 
(1). Briefly, confluent monolayers of Madin–Darby canine kidney 
(MDCK) cells were prepared in flasks 25 cm2 (Corning, Corning, 
New York, USA). The cell culture medium was removed, and the cell 
monolayers were washed 3 times with Minimum Essential Medium 
(MEM), pH 7.2, containing Earl’s salts, 3X antibiotic solution (peni-
cillin, 25 IU/mL; streptomycin, 75 mg/mL; gentamicin, 75 mg/mL; 
and amphotericin B, 3 mg/mL), and 5 mg/mL of trypsin treated with 
L-(tosylamido-2-phenyl) ethyl chloromethyl ketone (MEM/3X/Tr; 
Worthington Biochemical, Lakewood, New Jersey, USA). Next, 2 mL 
of the OF sample was placed in each flask and incubated at 37°C 
for 60 min, after which the inoculum was removed. The cell mono-
layers were rinsed 3 times with MEM/3X/Tr and then incubated 
for 5 to 7 d with 8 to 10 mL of MEM/3X/Tr. The cell cultures were 
examined for the appearance of cytopathic effect (CPE) daily. If CPE 
was present, the culture was tested by indirect fluorescent antibody 
(IFA) detection or rRT-PCR. Cells with no CPE were subjected to 
1 freeze–thaw cycle (at 280°C and 37°C) and reinoculated onto 
fresh MDCK cells. Contaminated cell-culture fluids were filtered 
(at 0.45 mm) (Millipore; Billerica, Massachusetts, USA) and reinocu-
lated onto fresh MDCK cells. Samples were considered IAV-negative 
if no CPE or IFA was detected after the 2nd passage in cell culture.
Procedure 2 — The following protocol is described in detail 
elsewhere (2). Briefly, confluent monolayers of MDCK cells were 
prepared in flasks 25 cm2. The cell culture medium was removed, 
and the cell monolayers were washed once with Hanks’ balanced 
salt solution (Gibco, Grand Island, New York, USA). Next, 0.5 mL 
of the OF sample was placed in each flask and incubated at 37°C for 
1 h, after which the inoculum was replaced with MEM plus Earl’s 
Salts and L-glutamine (Gibco), 2 mg/mL of sterile filtered trypsin 
from porcine pancreas (MP Biomedicals, Santa Ana, California, 
USA), and antibiotics (25 IU of penicillin and 25 mg of streptomycin). 
The cell cultures were incubated at 37°C in 5% CO2 and evaluated 
for the appearance of CPE daily for 5 to 7 d. If CPE was present, 
the culture was tested by IFA detection. Cells with no CPE were 
subjected to 1 freeze–thaw cycle (at −80°C and 37°C) and reinocu-
lated onto fresh MDCK cells. Contaminated cell-culture fluids were 
filtered (at 0.22 mm) (Acrodisc; Pall Corporation, Port Washington, 
New York, USA) and reinoculated onto fresh MDCK cells or else the 
original sample was retested. Samples were considered IAV-negative 
if no CPE or IFA was detected after the 2nd passage in cell culture.
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